When we analyzed the somatic mutations of genes related to brain tumor development, such as ARTX, BRAF, and MGMT, we identified more mutations in the PDX samples than in the original tumors (Figure 5 and Figure 7a). This evidence concerns the gene BRAF and brain neoplasm.